The whole blood assay: Detection of broad spectrum of pyrogens & examples of medical device testing
Merck Millipore
Update
Icon doubles down on devices with new research group
CRO Icon has launched a new medical device and diagnostics research group following the combination of recently acquired Aptiv Solutions ’ expertise with its own experts.
Patheon focuses on solubility with acquisition of Oregon-based CDMO
For the second time in just over a week, CDMO Patheon has made an acquisition, this time for Agere Pharmaceuticals, a privately held CDMO based in Bend, Oregon, that specializes in improving the bioavailability of drugs.
US FDA offers draft guidance on electronic informed consent
The draft guidance comes in the form of a Q&A and offers clinical investigators, IRBs and others a look into how electronic informed consent (eIC) should be done properly.
News in brief
CRO forum elects Quintiles, INC Research execs as chairs
The Association of Clinical Research Organizations (ACRO) held the inaugural meeting of the previously announced CRO Forum , which was established in October to increase interactions between the CRO industry and TransCelerate BioPharma.
Wuxi lowers projections for FY 2015 due to CapEx investments, stock takes 10% hit
Aggressive investment in new manufacturing capacity and new initiatives in genomics and cell therapy in 2015 is forcing CRO Wuxi to lower its expectations for 2015, and the lowered projections also seemed to have caused the company’s stock to fall by as much as 10% on Friday.
Global Industry News
Why PKC blockers failed in cancer: Research suggests former top drug targets suppress tumour growth
from in-PharmaTechnologist.com
Hundreds of API suppliers with plants in new Indian state Telangana need to update EDQM
from in-PharmaTechnologist.com
Production of wart drug with anti Ebola potential set to restart in New Jersey
from in-PharmaTechnologist.com
Hot topics
Spotlight
  Researchers enthusiastic over Obama’s new $215m precision medicine initiativeIn what was largely a pep rally for science, President Obama on Friday unveiled his $215m precision... |
 Parexel sees book-to-bill bounce back as GSK strategic partnership renewal bears fruitOne quarter after announcing a disappointing book-to-bill ratio, CRO Parexel has now renewed its strategic partnership with... |
 AstraZeneca turns to CRISPR for drug discovery; Are you watching Cellectis?AstraZeneca has partnered to use the CRISPR genome editing technique across its discovery programmes in a move... |
 HCV drugs Sovaldi and Olysio boost Q1 sales for AmeriSourceBergenNew hepatitis C drugs produced by Gilead, Janssen and AbbVie contributed to a first quarter spike in... |
 Strong US Dollar to hit revenues but strategic CROs may see lower costsThe strengthening US Dollar will reduce CRO revenues, say analysts, but firms which have global strategic deals... |
 Biosimulation – the next step in PK modelling embraced by regulatorsComputer-based drug modelling is moving from a discovery aid to a clinical tool accepted by regulators, according... |
